Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Fakilahyel S. Mshelbwala"'
Publikováno v:
Case Reports in Cardiology, Vol 2021 (2021)
Peri-stent contrast staining (PSS), defined as contrast staining around the stent struts, has been identified as an indicator of future stent failure in first generation, sirolimus-eluting coronary stents. 1 PSS has been associated with in-stent rest
Externí odkaz:
https://doaj.org/article/e3c1f9a448d842fd92f60dba2f263f9b
Publikováno v:
Journal of Nuclear Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6300fe718d3fa59ad365362e9b1ed595
https://doi.org/10.1007/s12350-022-02956-z
https://doi.org/10.1007/s12350-022-02956-z
Autor:
Mohammad Sabra, Rody G Bou Chaaya, Ziad A. Jaradat, Fakilahyel S. Mshelbwala, Omar Batal, Zeina Dardari, Rayan Jo Rachwan, Edward A. El-Am
Publikováno v:
The International Journal of Cardiovascular Imaging. 36:1953-1962
Negative stress echocardiography (NSE) is associated with low cardiovascular morbidity and overall mortality. We aimed to determine the clinical and echocardiographic predictors of overall and cardiovascular outcomes following NSE. Patients who under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a15c52c1111509741e72feb629d37f5
https://doi.org/10.1007/s10554-020-01913-6
https://doi.org/10.1007/s10554-020-01913-6
Publikováno v:
Clinical Pharmacology: Advances and Applications. 12:35-41
Background High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::924fcd0528678efcbb2cbd60d4890594
https://doi.org/10.2147/cpaa.s242675
https://doi.org/10.2147/cpaa.s242675
Publikováno v:
Journal of Thrombosis and Thrombolysis. 50:619-627
High on treatment platelet reactivity (HPR) during treatment with clopidogrel has been consistently found to be strong risk factor for recurrent ischemic events after percutaneous coronary intervention (PCI). Insufficient P2Y12 receptor inhibition co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::631c6a83f1417849c3432069071acb31
https://doi.org/10.1007/s11239-020-02075-x
https://doi.org/10.1007/s11239-020-02075-x
Autor:
Asad J. Torabi, Fakilahyel S. Mshelbwala, Daniel Hugenberg, Richard J. Kovacs, Rolf P. Kreutz
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 99(4)
The aim of this study was to assess neighborhood-based differences in outcomes of diabetics versus non-diabetics undergoing percutaneous coronary interventions. Disparities in healthcare access impact long-term outcomes in safety net populations. Dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32d54891b1b0e28f70ed53f0816bf91e
https://pubmed.ncbi.nlm.nih.gov/35094474
https://pubmed.ncbi.nlm.nih.gov/35094474
Publikováno v:
Case Reports in Cardiology, Vol 2021 (2021)
Case Reports in Cardiology
Case Reports in Cardiology
Peri-stent contrast staining (PSS), defined as contrast staining around the stent struts, has been identified as an indicator of future stent failure in first generation, sirolimus-eluting coronary stents. 1 PSS has been associated with in-stent rest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8454be53bffb8c8ccee6b75ca1ab93d2
https://doaj.org/article/e3c1f9a448d842fd92f60dba2f263f9b
https://doaj.org/article/e3c1f9a448d842fd92f60dba2f263f9b
Autor:
Rody G Bou Chaaya, Edward A. El-Am, Marco A. Lacerda, Patrick V Bourdillon, Fakilahyel S Mshelbwala, Rayan Jo Rachwan, Chandrashekhar A. Kubal, Mohamad Sabra, Jonathan A. Fridell, Mahmoud A. Rahal, Issa Kutkut, Marwan Ghabril, Lava Timsina, Richard S. Mangus
Publikováno v:
Circulation. 142
Background: Patients with significant coronary artery disease (CAD) are more likely to develop post-liver transplant (LT) cardiac events. We developed the CAD-LT screening score and testing algorithm to predict the risk of significant CAD in LT candi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcc81ea4c49f8f22f909a206b840f02
https://doi.org/10.1161/circ.142.suppl_3.15844
https://doi.org/10.1161/circ.142.suppl_3.15844
Autor:
Rayan Jo, Rachwan, Fakilahyel S, Mshelbwala, Rody G, Bou Chaaya, Edward A, El-Am, Mohammad, Sabra, Zeina, Dardari, Ziad A, Jaradat, Omar, Batal
Publikováno v:
The international journal of cardiovascular imaging. 36(10)
Negative stress echocardiography (NSE) is associated with low cardiovascular morbidity and overall mortality. We aimed to determine the clinical and echocardiographic predictors of overall and cardiovascular outcomes following NSE. Patients who under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a2502040badd9601b56d1f444be7493
https://pubmed.ncbi.nlm.nih.gov/32757119
https://pubmed.ncbi.nlm.nih.gov/32757119
Publikováno v:
Clinical Pharmacology : Advances and Applications
Background High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27d4306fec41639cdab761b77a8ef41b
https://pubmed.ncbi.nlm.nih.gov/32368161
https://pubmed.ncbi.nlm.nih.gov/32368161